Therasense Inc
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of oncology products in the United States. The company offers patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It also provides precision … Read more
Market Cap & Net Worth: Therasense Inc (THER)
Therasense Inc (PINK:THER) has a market capitalization of $615.15K ($615.15K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #40835 globally and #13246 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Therasense Inc's stock price $0.00 by its total outstanding shares 6151499919 (6.15 Billion).
Therasense Inc Market Cap History: 2015 to 2025
Therasense Inc's market capitalization history from 2015 to 2025. Data shows change from $27.69 Trillion to $615.15K (-81.88% CAGR).
Therasense Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Therasense Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
15.21x
Therasense Inc's market cap is 15.21 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $544.54 Billion | $74.00 | -$990.40K | 7358698526.75x | N/A |
| 2020 | $1.23 Billion | $181.23K | -$3.17 Million | 6788.65x | N/A |
| 2021 | $9.17 Billion | $505.60K | -$5.59 Million | 18128.29x | N/A |
| 2022 | $20.92 Million | $567.90K | -$12.75 Million | 36.83x | N/A |
| 2023 | $9.23 Million | $606.80K | -$30.91 Million | 15.21x | N/A |
Competitor Companies of THER by Market Capitalization
Companies near Therasense Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Therasense Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Therasense Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Therasense Inc's market cap moved from $27.69 Trillion to $ 615.15K, with a yearly change of -81.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $615.15K | 0.00% |
| 2024 | $615.15K | -93.33% |
| 2023 | $9.23 Million | -55.88% |
| 2022 | $20.92 Million | -99.77% |
| 2021 | $9.17 Billion | +645.00% |
| 2020 | $1.23 Billion | +108.33% |
| 2019 | $590.54 Million | -98.79% |
| 2018 | $48.92 Billion | -76.44% |
| 2017 | $207.66 Billion | -61.86% |
| 2016 | $544.54 Billion | -98.03% |
| 2015 | $27.69 Trillion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Therasense Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $615.15K USD |
| MoneyControl | $615.15K USD |
| MarketWatch | $615.15K USD |
| marketcap.company | $615.15K USD |
| Reuters | $615.15K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.